ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

New MEDITECH Expanse Pathology Solution Streamlines Pathologist Workflows

The web-native design brings pathologists to the forefront of advancing care and connecting data throughout the EHR.

MEDITECH announces the release of its redesigned Expanse Pathology solution — one of the company’s latest innovations in its Expanse EHR. As the pathology industry trends towards more specialized imaging and advanced integrated reporting with genetic results, Expanse Pathology provides the technology pathologists need to assist with the most complicated cases.

Expanse Pathology includes a new, streamlined workflow with an intuitive and personalizable space for pathologists aiming to reduce the cognitive burden of technically complicated tasks. Designed to support web-native navigation, Expanse Pathology positions laboratories to leverage the latest advancements in the pathology market today and in the future.

“As clinicians everywhere face burnout, the ability to leverage user-tailored worklists, capture findings efficiently using the latest technologies, and easily edit and sign out cases will save pathologists valuable time,” said MEDITECH Manager of Clinical Strategy Jennifer Ford.

“Plus, with the integration between Expanse Pathology and other groundbreaking MEDITECH solutions like Expanse Genomics and Expanse Oncology, we can drive better patient care and help pathologists connect the intricate dots of data throughout the Electronic Health Record, enabling true precision medicine.”

Expanse's inherent integration brings the most important members of the care team into the loop when it matters. Pathologists can easily share important key findings with other clinicians and leverage Expanse Genomics to push key data to the forefront. In addition, synoptic reporting staging within Expanse Pathology flows directly to Expanse Oncology to assist oncologists and other clinicians while performing staging and making significant decisions about patient care.

“Pathologists are such an important part of a patient’s care team,” said Ford. “MEDITECH Expanse Pathology removes silos by providing pathologists with the tools necessary to increase efficiency and easily communicate information across the entire pathology department and beyond — from OB to Oncology — ensuring timely access to the most relevant information.”

Visit MEDITECH in booth #2580 at #HIMSS24 to learn more about Expanse Pathology.

About MEDITECH

MEDITECH empowers healthcare organizations around the globe to expand their vision of what’s possible with Expanse, the world’s most intelligent EHR platform. Expanse answers the demands of an overburdened workforce: personalized workflows, intuitive functionality, interoperable systems, and innovative AI applications, all working together to drive better outcomes. See why thousands of healthcare organizations in 27 countries and territories choose Expanse. Visit ehr.meditech.com and follow us on YouTube, LinkedIn, X/Twitter, Facebook, Instagram, and Threads.

MEDITECH announces the release of its newly redesigned #Expanse Pathology solution — one of the company’s latest innovations in its Expanse EHR. @MEDITECH #Pathology #EHR

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.